NAN
$1.1BCF+
Nanosonics
Medical Devices · Infection prevention
Trophon ultrasound probe disinfection platform, expanding into endoscope reprocessing
Cash data from Dec 2025 4CFigures from ASX filings · not financial advice
[ VITALS ]
Cash on Hand
$144.5M
Dec 2025 4C
Runway
CF+Cash Flow Positive
Based on Dec 2025 4C
Market Cap
$1.1B
Burn Rate
—
Dec 2025 4C
Shares Outstanding
303M
Pipeline Assets
2
Latest Insight(1)
20 Apr 2026substantial_holderBecoming a substantial holder
New holder·UBS Group AG and its related bodies corporate·5.34%
3M Price
NAN.ASX$3.550-10.6% 3M
Low $3.240High $4.010
Pipeline Assets (2)
CORISEndoscope reprocessing
Phase 2Trophon2Ultrasound probe disinfection
ApprovedDiscovery
Preclinical
Ph 1
Ph 1/2
Ph 2
Ph 2/3
Ph 3
NDA
Approved
CORIS
Endoscope reprocessing
Capital Raises & Buybacks
17 buybacks
Current shares outstanding: 303M
Buyback
Substantial Holders (5%+ threshold)
7 noticesINITIALUBS Group AG and its related bodies corporate
5.34%2026-04-20
CEASEDUBS Group AG and its related bodies corporate
INITIALUBS Group AG and its related bodies corporate
5.69%
Director Options & Rights
Director
Outstanding
Ex. Price
Expiry
No option data entered yet
Short Interest
ASIC ↗as of 2026-03-27 · 4-day lag
Short position
11.78%
arrow_drop_up+1.62% over 30 reports
Shares short
35.7M
Aggregated short position data published by ASIC under the Corporations Act. T+4 reporting lag applies. Short interest ≥5% is noteworthy; ≥10% is elevated. Source: ASIC Short Selling Data
expand_moreClinical Publications
Peer-reviewed papers & conference abstracts via PubMed
15 papers
Clinical Publications
Peer-reviewed papers & conference abstracts via PubMed
Braz J Infect Dis· CORIS
J Med Virol2026-04· CORIS
Int J Infect Dis2026-03· CORIS
Catalysts (2)
Trophon installed base growth
UpcomingConfirmedremoveMed30 Apr 2026
CORIS endoscope reprocessing update
UpcomingExpectedremoveMed30 June 2026
| Event | Type | Confidence | Impact | Date | Status |
|---|---|---|---|---|---|
| Trophon installed base growth Quarterly update on global Trophon2 installed base expansion | commercial milestone | Confirmed | removeMed |
Delivery Consistency Index
Historical delivery and spending consistency — data is limited for recently added companies.
Track record will build as data accumulates — we need completed catalysts with original guidance dates, or at least two quarterly 4Cs, before scoring kicks in.